Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic MechanismsPanos Zanos, Todd D. Gould|Pharmacological Reviews|2018Cited by 1.2k
In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3Todd D. Gould, Husseini K. Manji|Neuropsychopharmacology|2003Cited by 216
β-Catenin Overexpression in the Mouse Brain Phenocopies Lithium-Sensitive BehaviorsTodd D. Gould, Husseini K. Manji|Neuropsychopharmacology|2007Cited by 137
Experimenters’ sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factorPolymnia Georgiou, Todd D. Gould|Nature Neuroscience|2022Cited by 133
NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of KetaminePanos Zanos, Todd D. Gould|Journal of Neuroscience|2023Cited by 104